FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
The FDA has issued a discussion paper outlining regulatory considerations for generative AI-enabled medical devices, including safety risk assessment, premarket review, and ongoing performance monitoring. Stakeholders are invited to comment on how best to ensure timely access to innovative AI tools while maintaining patient safety and device effectiveness.
About LOG Standards
LOG Standards provides an independent accreditation signal for AI models used in healthcare, helping hospitals, care networks, and AI companies bring clinical AI readiness and governance into clearer conversations.
Our AI Intelligence Briefing tracks the latest developments in AI safety, AI in medicine, mental health AI, clinical AI governance, and regulatory policy — keeping healthcare stakeholders informed about the rapidly evolving AI landscape.